On the other hand, Green et al. showed that n-6 DPA reduced levels of phospho-tau involved in the pathology of AD, and suggested that a combination of DHA + n-6 DPA may be a beneficial natural therapeutic strategy for AD. This evidence concerns the gene MAPT and Alzheimer disease.